logo
16:01 Mar 05

Oxygenta Pharmaceutical Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
50.35
+0.35 (+0.70%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Oxygenta Pharmaceutical Ltd. Financials

Oxygenta Pharmaceutical Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
50.35
+0.35 (+0.70%)
16:01 Mar 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

12/100
Expensive Valuation

Technical

28/100
Technically Bearish

Strength

6

Weakness

8

Opportunity

1

Threats

0

-7.70 %

ROE %

-11.60 %

ROA %

0.00

EPS

-6.77

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
52.03 60.52 30.99 39.64 109.3
Operating Expenses +
48.18 59.06 38.1 49.34 119.29
Raw Material
43.02 42.67 28.13 35.06 100.23
Increase Decrease in Cost
-6.39 4.55 -4.63 -1.53 -3.76
Other Manufacturing Expense
5.67 5.45 11.73 7.44 11.16
Employee Cost
4.21 4.6 1.24 5.99 6.9
Miscellaneous Expenses
1.67 1.79 1.63 2.38 4.76
Operating Profit
3.85 1.46 -7.11 -9.7 -9.99
Other Income
0.09 0 0.02 0.04 1.31
Depreciation
1.2 1.59 2.05 2.66 0.82
Interest
1.78 0.92 1.49 1.59 1.78
Profit before tax and exceptio..
0.95 -1.04 -10.64 -13.91 -11.28
Exceptional Items
2.19 0.55 -0.73 0.04 -0.27
PBT
3.14 -0.49 -11.37 -13.87 -11.55
Provision for Taxation
0.21 0.12 0.2 -10.39 -1.87
Net Profit
2.93 -0.61 -11.57 -3.48 -9.68
NET Profit after MI
0 0 0 0 0
EPS
2.87 -0.48 -8.15 -1.09 -2.69
Operating Profit Margin (%)
7.4 2.41 -22.94 -24.47 -9.14
Net Profit Margin (%)
5.63 -1.01 -37.33 -8.78 -8.86

Oxygenta Pharmaceutical Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: